PL338510A1 - Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4 - Google Patents
Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4Info
- Publication number
- PL338510A1 PL338510A1 PL98338510A PL33851098A PL338510A1 PL 338510 A1 PL338510 A1 PL 338510A1 PL 98338510 A PL98338510 A PL 98338510A PL 33851098 A PL33851098 A PL 33851098A PL 338510 A1 PL338510 A1 PL 338510A1
- Authority
- PL
- Poland
- Prior art keywords
- inhinbiting
- leucocytes
- vla
- mediation
- adhesion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90358597A | 1997-07-31 | 1997-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL338510A1 true PL338510A1 (en) | 2000-11-06 |
Family
ID=25417733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98338510A PL338510A1 (en) | 1997-07-31 | 1998-07-31 | Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1001975A1 (xx) |
JP (1) | JP2001512138A (xx) |
KR (1) | KR20010022413A (xx) |
CN (1) | CN1265675A (xx) |
AU (1) | AU8585198A (xx) |
BR (1) | BR9811573A (xx) |
CA (1) | CA2291473A1 (xx) |
HU (1) | HUP0002680A3 (xx) |
IL (1) | IL133635A0 (xx) |
NO (1) | NO20000414L (xx) |
PL (1) | PL338510A1 (xx) |
WO (1) | WO1999006436A1 (xx) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
AU7667498A (en) * | 1997-05-30 | 1998-12-30 | Celltech Therapeutics Limited | Anti-inflammatory tyrosine derivatives |
GB2365338B (en) * | 1997-06-14 | 2002-04-03 | Enzacta R & D Ltd | Therapeutic systems |
ATE249421T1 (de) | 1997-06-23 | 2003-09-15 | Tanabe Seiyaku Co | Inhibitoren der alpha4-beta1 vermittelten zelladhäsion |
US6489300B1 (en) | 1997-07-31 | 2002-12-03 | Eugene D. Thorsett | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6939855B2 (en) | 1997-07-31 | 2005-09-06 | Elan Pharmaceuticals, Inc. | Anti-inflammatory compositions and method |
US6559127B1 (en) | 1997-07-31 | 2003-05-06 | Athena Neurosciences, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6362341B1 (en) | 1997-07-31 | 2002-03-26 | Athena Neurosciences, Inc. | Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US7030114B1 (en) | 1997-07-31 | 2006-04-18 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6583139B1 (en) | 1997-07-31 | 2003-06-24 | Eugene D. Thorsett | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6492421B1 (en) | 1997-07-31 | 2002-12-10 | Athena Neurosciences, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6423688B1 (en) | 1997-07-31 | 2002-07-23 | Athena Neurosciences, Inc. | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6197794B1 (en) * | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
AU3260399A (en) | 1998-02-26 | 1999-09-15 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
US6685617B1 (en) | 1998-06-23 | 2004-02-03 | Pharmacia & Upjohn Company | Inhibitors of α4β1 mediated cell adhesion |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
US6333340B1 (en) * | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
US6407066B1 (en) | 1999-01-26 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
DK2140881T3 (da) * | 1999-12-16 | 2013-05-06 | Biogen Idec Inc | Fremgangsmåder til behandling af iskæmisk eller hæmoragisk læsion i centralnervesystemet ved anvendelse af anti-alpha-4-integrin-antagonister |
US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
NZ518886A (en) | 1999-12-28 | 2004-02-27 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
EP1332132B1 (en) | 2000-04-17 | 2007-10-10 | UCB Pharma, S.A. | Enamine derivatives as cell adhesion molecules |
US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
US6960597B2 (en) * | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
US6740654B2 (en) | 2000-07-07 | 2004-05-25 | Celltech R & D Limited | Squaric acid derivatives |
EP1305291A1 (en) | 2000-08-02 | 2003-05-02 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
JP2005022976A (ja) * | 2001-07-18 | 2005-01-27 | Ajinomoto Co Inc | カルボン酸誘導体 |
MY140707A (en) | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
CA2477265A1 (en) * | 2002-03-28 | 2003-10-09 | Applied Research Systems Ars Holding N.V. | Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor |
EP1592387A4 (en) * | 2003-01-24 | 2009-05-06 | Elan Pharm Inc | COMPOSITION AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS |
WO2005118538A2 (en) * | 2004-04-20 | 2005-12-15 | Amgen, Inc. | Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
DK1778637T3 (da) * | 2004-06-29 | 2012-06-18 | Aventis Pharma Inc | FKBP-bindingssammensætninger og farmaceutisk anvendelse deraf |
CA2714335A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
KR20110008086A (ko) | 2008-04-11 | 2011-01-25 | 메리맥 파마슈티컬즈, 인크. | 인간 혈청 알부민 링커 및 그 콘쥬게이트 |
PL3202789T3 (pl) | 2010-04-16 | 2020-09-21 | Biogen Ma Inc. | Przeciwciała anty-vla-4 |
CN102675244B (zh) * | 2011-03-16 | 2016-03-30 | 中国人民解放军军事医学科学院毒物药物研究所 | 噻嗪酰胺衍生物及其在制备神经退行性疾病防治药物的用途 |
KR20170052526A (ko) | 2014-03-13 | 2017-05-12 | 프로테나 바이오사이언시즈 리미티드 | 다발성 경화증에 대한 병용 치료 |
JP7457661B2 (ja) | 2018-06-04 | 2024-03-28 | バイオジェン・エムエイ・インコーポレイテッド | 低減したエフェクター機能を有する抗vla-4抗体 |
EP3873900A1 (en) | 2018-10-30 | 2021-09-08 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
EP3873897B1 (en) | 2018-10-30 | 2024-08-14 | Gilead Sciences, Inc. | N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases |
US11179383B2 (en) | 2018-10-30 | 2021-11-23 | Gilead Sciences, Inc. | Compounds for inhibition of α4β7 integrin |
WO2020092375A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Quinoline derivatives as alpha4beta7 integrin inhibitors |
CN114222730B (zh) | 2019-08-14 | 2024-09-10 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04154732A (ja) * | 1990-10-18 | 1992-05-27 | Nippon Kayaku Co Ltd | 光学分割法 |
AU693143B2 (en) * | 1993-12-06 | 1998-06-25 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
-
1998
- 1998-07-31 IL IL13363598A patent/IL133635A0/xx unknown
- 1998-07-31 CN CN98807764A patent/CN1265675A/zh active Pending
- 1998-07-31 AU AU85851/98A patent/AU8585198A/en not_active Abandoned
- 1998-07-31 BR BR9811573-1A patent/BR9811573A/pt not_active Application Discontinuation
- 1998-07-31 CA CA002291473A patent/CA2291473A1/en not_active Abandoned
- 1998-07-31 WO PCT/US1998/015327 patent/WO1999006436A1/en not_active Application Discontinuation
- 1998-07-31 PL PL98338510A patent/PL338510A1/xx unknown
- 1998-07-31 JP JP2000505191A patent/JP2001512138A/ja not_active Withdrawn
- 1998-07-31 EP EP98937054A patent/EP1001975A1/en not_active Withdrawn
- 1998-07-31 KR KR1020007000993A patent/KR20010022413A/ko not_active Application Discontinuation
- 1998-07-31 HU HU0002680A patent/HUP0002680A3/hu unknown
-
2000
- 2000-01-27 NO NO20000414A patent/NO20000414L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010022413A (ko) | 2001-03-15 |
CN1265675A (zh) | 2000-09-06 |
HUP0002680A2 (hu) | 2001-07-30 |
WO1999006436A1 (en) | 1999-02-11 |
NO20000414D0 (no) | 2000-01-27 |
BR9811573A (pt) | 2000-09-19 |
IL133635A0 (en) | 2001-04-30 |
NO20000414L (no) | 2000-03-28 |
EP1001975A1 (en) | 2000-05-24 |
HUP0002680A3 (en) | 2001-12-28 |
JP2001512138A (ja) | 2001-08-21 |
CA2291473A1 (en) | 1999-02-11 |
AU8585198A (en) | 1999-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL338510A1 (en) | Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338521A1 (en) | Carbamyloxylic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338506A1 (en) | Compounds inhibiting adhesion of leucocytes occuring through the mediation of vla-4 | |
PL338554A1 (en) | Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338423A1 (en) | Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338457A1 (en) | Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338373A1 (en) | Dipeptide and its affinite compounds inhibiting adhesion of leucocytes occurring through mediation of vla-4 | |
PL338413A1 (en) | Compound of 4-amino phenylalanine type inhibiting adhesion of leucocytes through the meditation of vla-4 | |
IL127563A0 (en) | Cell adhesion inhibiting compounds | |
GB9805214D0 (en) | Cell adhesion | |
GB9720922D0 (en) | Adhesives | |
TW299073U (en) | Battery assembly | |
ZA984088B (en) | Antithrombotic compound. | |
GB9926537D0 (en) | Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds | |
ZA966292B (en) | Adhesive fastening arrangement. | |
EP1028947B8 (en) | H3 receptor ligands of the phenyl-alkyl-imidazoles type | |
GB9711118D0 (en) | Compound | |
AUPO691897A0 (en) | New compound | |
GB9515173D0 (en) | The fighting flex | |
GB9706377D0 (en) | Novel compound | |
AU8546598A (en) | Cartridge | |
HU9700260V0 (en) | Arrangement for commercial over the telephone | |
AU6507998A (en) | Distributed telephony management | |
GB9716429D0 (en) | The other option | |
GB9726340D0 (en) | Compound |